Olivier Danos

Olivier Danos was the founder of Lysogene SA, founded in 2009, and served as Director from 2017 to 2018.
Current jobs include Chairman-Scientific Advisory Board at Firalis SA since 2012, Independent Non-Executive Director at Horama SA since 2021, Director at Profilomic SA since 2016, Director at uniQure France SAS, and Chief Scientific Officer & EVP at REGENXBIO, Inc. since 2017.
Former jobs include Senior Director-Research at Somatix Therapy Corp.
from 1994 to 1996, Research Director at Centre National de la Recherche Scientifique, Director-Gene Therapy Consortium at University College London from 2008 to 2011, Senior Vice President-Cell & Gene Therapy at Biogen, Inc. from 2014 to 2017, President & Founding Member at European Society of Gene & Cell Therapy, Chief Scientific Officer at Genethon from 1998 to 2005, and Senior VP-Molecular Medicine & Synthetic Biology at Kadmon Pharmaceuticals LLC from 2011 to 2014.
Education includes graduate studies at the University of Orsay and a doctorate from Université Paris Diderot-Paris 7.
Dr. Danos is the founder.